Dimopoulos MA - Search Results

1

Predictive factors for effective salvage therapy of nonseminomatous germ cell tumors of testis.

Dimopoulos MA, Amato RJ, Logothetis CJ. Dimopoulos MA, et al. Urology. 1991 Oct;38(4):351-4. doi: 10.1016/0090-4295(91)80151-v. Urology. 1991. PMID: 1661457

2

Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy.

Dimopoulos MA, Finn L, Logothetis CJ. Dimopoulos MA, et al. J Urol. 1994 Mar;151(3):598-600; discussion 600-1. doi: 10.1016/s0022-5347(17)35025-5. J Urol. 1994. PMID: 8308966

3

Collecting duct carcinoma of the kidney.

Dimopoulos MA, Logothetis CJ, Markowitz A, Sella A, Amato R, Ro J. Dimopoulos MA, et al. Br J Urol. 1993 Apr;71(4):388-91. doi: 10.1111/j.1464-410x.1993.tb15978.x. Br J Urol. 1993. PMID: 8499979

4

Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinoma.

Mitropoulos D, Dimopoulos MA, Kiroudi-Voulgari A, Zervas A, Dimopoulos C, Logothetis CJ. Mitropoulos D, et al. Among authors: dimopoulos c, dimopoulos ma. J Urol. 1994 Oct;152(4):1124-6. doi: 10.1016/s0022-5347(17)32520-x. J Urol. 1994. PMID: 8072080

5

Late relapse of nonseminomatous germ cell tumor of the testis: successful treatment with salvage chemotherapy alone.

Papadimitris C, Papadimitriou C, Kokolakis N, Athanassiades P, Dimopoulos MA. Papadimitris C, et al. Among authors: dimopoulos ma. Urology. 1997 Mar;49(3):469-70. doi: 10.1016/S0090-4295(96)00495-5. Urology. 1997. PMID: 9123720 Review.

6

Early myeloablative therapy for multiple myeloma.

Alexanian R, Dimopoulos MA, Hester J, Delasalle K, Champlin R. Alexanian R, et al. Among authors: dimopoulos ma. Blood. 1994 Dec 15;84(12):4278-82. Blood. 1994. PMID: 7994043 Free article.

7

Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.

Touroutoglou N, Dimopoulos MA, Younes A, Hess M, Pugh W, Cox J, Cabanillas F, Sarris AH. Touroutoglou N, et al. Among authors: dimopoulos ma. J Clin Oncol. 1995 Jun;13(6):1361-7. doi: 10.1200/JCO.1995.13.6.1361. J Clin Oncol. 1995. PMID: 7751880

8

Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma.

Dimopoulos MA, Delasalle KB, Champlin R, Alexanian R. Dimopoulos MA, et al. Br J Haematol. 1993 Feb;83(2):240-4. doi: 10.1111/j.1365-2141.1993.tb08278.x. Br J Haematol. 1993. PMID: 8457473 Clinical Trial.

9

Primary parotid lymphoma: the effect of International Prognostic Index on outcome.

Sarris AH, Papadimitrakopoulou V, Dimopoulos MA, Smith T, Pugh W, Ha CS, McLaughlin P, Callender D, Cox J, Cabanillas F. Sarris AH, et al. Among authors: dimopoulos ma. Leuk Lymphoma. 1997 Jun;26(1-2):49-56. doi: 10.3109/10428199709109157. Leuk Lymphoma. 1997. PMID: 9250787

10

High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma.

Dimopoulos MA, Barlogie B, Smith TL, Alexanian R. Dimopoulos MA, et al. Ann Intern Med. 1991 Dec 15;115(12):931-5. doi: 10.7326/0003-4819-115-12-931. Ann Intern Med. 1991. PMID: 1952489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,277 results

Search Page